SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

Phytosphingosine & Sphingolipids: Ceramide alternative with higher bioavailability

In cosmetics, phytosphingosine and sphingolipids refer to structurally related lipid classes that act as functional alternatives or supplements to ceramides in the skin barrier. Phytosphingosine is an amino alcohol lipid occurring naturally in the epidermis, which is considered a direct precursor to the body’s own ceramides and, due to its smaller molecular size, exhibits higher bioavailability in the stratum corneum compared to classic ceramide formulations.

Term and Origin

The term sphingolipid was coined in 1884 by the German chemist Johann Ludwig Wilhelm Thudichum when he isolated a mysterious lipid class in the brain whose biological function he could not fully explain. He chose the name in reference to the Sphinx — a nod to the enigmatic nature of the compounds. The sphingolipid class includes ceramides, sphingomyelin, glucosylceramides, and phytosphingosines, all linked by a common structural backbone: the long-chain amino alcohol base sphingosine, or its plant-based analog, phytosphingosine.

Phytosphingosine (INCI: Phytosphingosine) occurs in nature primarily in yeast, fungi, plant tissues, and — in small amounts — in the human epidermis, particularly in the upper layers of the stratum spinosum and stratum granulosum. It differs from animal sphingosine by an additional hydroxyl group at position 4 of the carbon chain, which makes it chemically more stable and biologically active in the context of the epidermal barrier. In modern cosmetic formulation, phytosphingosine is usually obtained biotechnologically from yeast (Saccharomyces cerevisiae), making it a vegan and reproducibly pure raw material.

The scientific study of sphingolipids in dermatology gained significant momentum in the late 1990s after research groups led by Peter Elias (UCSF) and Lars Norlén systematically described the link between ceramide deficiency and a disrupted skin barrier in atopic dermatitis. Phytosphingosine only moved into the cosmetic spotlight later — around 2005 — when it was shown that it not only serves as a ceramide precursor but also possesses its own antimicrobial and inflammation-modulating properties.

Characteristics & Mechanism of Action

Together with ceramides, free fatty acids, and cholesterol, sphingolipids form the so-called lamellar structure of the stratum corneum — a highly ordered, intercellular lipid mosaic that regulates transepidermal water loss (TEWL) and protects the skin from the penetration of irritants, allergens, and microorganisms. While applied ceramides struggle to penetrate intact lipid bilayers due to their large, amphiphilic molecular structure, phytosphingosine has a significantly more compact molecular geometry. This allows for more efficient integration into existing lamellar structures and — crucially — enzymatic conversion into endogenous ceramides by the skin's own ceramide synthase.

The mechanism of action is therefore multi-stage: First, phytosphingosine acts directly as a barrier-active lipid; second, it functions as a substrate for ceramidase-mediated synthesis of the body's own ceramide 1, 3, and 6-II types in the stratum granulosum. Third, phytosphingosine has been described in vitro as an inhibitor of phospholipase A2 and as a modulator of proinflammatory cytokines such as IL-1α and TNF-α. This combination of lipid-structural and inflammation-regulatory effects conceptually distinguishes it from purely film-forming ceramide formulations, which primarily aim for an occlusive barrier effect.

Within the sphingolipid family, glucosylceramide (a glycosylated sphingolipid) is also cosmestically relevant: it occurs naturally in wheat, konjac, and rice and is being studied as a barrier modulator for both oral and topical use. Unlike phytosphingosine, it acts primarily through signaling pathways of keratinocyte proliferation and differentiation, rather than as a direct ceramide precursor. Both substance classes are referred to in technical literature under the umbrella term “bioidentical lipids,” although this term is not regulated or standardized.

Skincare Approach

In practical application, sphingolipids and phytosphingosine are particularly relevant for formulations focused on barrier restoration and moisture retention. Understanding the underlying ceramide biochemistry is helpful here, as phytosphingosine and classic ceramides can work synergistically: while ceramides build occlusive structures, phytosphingosine provides metabolically active precursor material. Equally relevant is the connection to the general skin barrier: an intact barrier requires not only sufficient ceramides but also a balanced ratio of all lipid classes in the stratum corneum.

Concentration specifications for phytosphingosine in cosmetic formulations typically range between 0.05% and 0.5%. Higher concentrations are rarely useful in rinse-off products; leave-on formulations — preferably serums, emulsions, or light facial oils — allow for longer contact time and promote enzymatic conversion. So-called layering plays a role: formulations containing sphingolipids benefit from being applied after water-based steps and before final oils or creams, as this favors the penetration depth into the lipid matrix.

Anyone combining phytosphingosine with other barrier-active ingredients should also consider the chronobiological dimension: skin renewal rates, ceramide synthesis, and lipid lamellar structuring show distinct circadian rhythms. NATURFACTOR® has anchored this logic as a central formulation principle — for details on the temporal coordination of active ingredients, please refer to the article on the chronobiology of the skin. Within the NATURFACTOR® Day Rhythm and Night Rhythm routine, the Porcelain Skin Serum (30 ml) acts as a daytime treatment with ingredients for moisture retention and barrier function, including two forms of hyaluronic acid, pullulan, amino acid-based active ingredients, and functional silk polypeptides. Complementing this, the Blue Crystal Drops (30 ml) acts as a nighttime facial oil with bioactive phytosterols, bisabolol, and essential oils of blue lotus and blue tansy for nocturnal regeneration and antioxidant protection. Both products are available in The Perfect Duo. Since phytosphingosine is not a component of these products itself, we additionally refer to chronobiology of the skin for its classification within the time-controlled rhythm.

Realistic Expectations

Sphingolipids and phytosphingosine are not "instant" ingredients in terms of visible effects within a few hours. The regeneration of the lipid lamellar structure in the stratum corneum is a biological process linked to the keratinocyte differentiation cycle — which takes about 14 to 28 days in healthy adults. Clinical studies on phytosphingosine-containing formulations typically show measurable improvements in TEWL (transepidermal water loss) and barrier function after 4 to 8 weeks of regular use.

Individual variation is significant: skin with pronounced ceramide deficiency (e.g., in eczematous or chronically stressed skin) generally reacts faster and more clearly to sphingolipid supplementation than normolipemic skin. Furthermore, the effect depends significantly on formulation quality: in clinical comparisons, phytosphingosine in an aqueous solution without suitable penetration enhancers shows a weaker barrier effect than phytosphingosine in a lipid or lamellar-structured matrix. The higher raw material price of phytosphingosine compared to synthetic ceramides is justified from a formulation perspective if the bioavailability is actually utilized by the overall system.

Frequently Asked Questions

Is phytosphingosine the same as ceramides?

No. Phytosphingosine is a sphingolipid and a structural precursor to ceramides, not identical to them. In the stratum corneum, phytosphingosine can be enzymatically converted into the body's own ceramides, but also acts independently to stabilize the barrier and modulate inflammation. Classic ceramide formulations provide the finished end-molecule and act primarily through integration into the lipid lamellar structure, whereas phytosphingosine can additionally serve the endogenous ceramide biosynthesis pathway.

Why are phytosphingosines considered more expensive than standard ceramides?

The production of high-purity phytosphingosine requires biotechnological fermentation processes using yeast (typically Saccharomyces cerevisiae), followed by multi-stage chromatographic purification and strict quality controls. Synthetic ceramides can be produced more easily on a large industrial scale. Depending on the degree of purity and the supplier, the price difference is by a factor of 3 to 10, which is reflected in the formulation costs.

For which skin types is phytosphingosine suitable?

Phytosphingosine is generally suitable for all skin types, as it is a substance naturally present in the human epidermis and is considered well-tolerated. Particularly clear effects are seen in skin with limited barrier function, i.e., in dry, dehydrated, eczematous, or age-related lipid-depleted skin. Sensitive skin also benefits from the inflammation-modulating component. At higher concentrations (above 0.3%), tolerance should be tested individually, as isolated cases of intolerance have been documented.

Conclusion

Phytosphingosine and sphingolipids are not a marketing innovation, but biochemically sound supplements to classic ceramide therapy for the skin. Their strength lies in the dual mechanism of action: structural barrier effect combined with the ability to support the endogenous ceramide biosynthesis pathway. The higher formulation effort and raw material price are justified when the overall formulation actually makes the increased bioavailability usable. For daily skincare, this means: sphingolipid-containing products unfold their potential best in leave-on formulations with a suitable carrier matrix, applied consistently over several weeks, ideally embedded in a chronobiologically coordinated routine. The connection between lipid classes, barrier rhythm, and time-controlled formulation approaches is a growing field of research — one that replaces the question “Which active ingredient?” with the more precise question: “Which active ingredient, when, and in which carrier matrix?”

1. Elias PM, Feingold KR. (1992). Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Seminars in Dermatology, 11(2), 176–182.
2. Wertz PW. (2000). Lipids and barrier function of the skin. Acta Dermato-Venereologica Supplementum, 208, 7–11.
3. Pavicic T, Wollenweber U, Farwick M, Korting HC. (2007). Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. International Journal of Cosmetic Science, 29(3), 181–190.
4. Uchida Y, Holleran WM. (2008). Omega-O-acylceramide, a lipid essential for mammalian survival. Journal of Dermatological Science, 51(2), 77–87.
5. Loden M. (2003). Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. American Journal of Clinical Dermatology, 4(11), 771–788.